Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact
Tickers BIIB ESALY NEWS
Tags pharmaceuticals ESALY Earnings
From Benzinga
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
Tickers BIIB ESALY LLY NEWS
Tags Biotech ESALY Stories That Matter
From Benzinga
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Tickers BIIB ESALY NEWS
Tags FDA Benzinga Stories That Matter
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Tickers BIIB ESALY NEWS SHL
Tags News BIIB Analyst Color
From Benzinga
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Tickers BIIB ESALY LLY NEWS
Tags Eurozone Benzinga Stories That Matter
From Benzinga
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Tickers BIIB ESALY NEWS
Tags Health Care Stories That Matter Benzinga
From Benzinga
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
Tickers BIIB ESALY
Tags Recent Press Releases Market News BIIB
From Motley Fool
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Tickers BIIB ESALF ESALY LLY
Tags Stories That Matter Benzinga Health Care
From Benzinga
This Is Massive News for Eli Lilly Investors
Tickers BIIB ESALY LLY NVO
Tags Recent Press Releases BIIB ESALY
From Motley Fool
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Tickers BIIB ESALY NEWS
Tags BIIB News General
From Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
Tickers BIIB ESALF ESALY NEWS
Tags Benzinga Stories That Matter Health Care
From Benzinga
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
Tickers BIIB ESALY LLY NEWS
Tags Stories That Matter Benzinga FDA
From Benzinga
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
Tickers BIIB ESALY NEWS NVS
Tags Health Care Benzinga Trading Ideas
From Benzinga
Why Is Biogen Stock Trading Lower On Tuesday?
Tickers BIIB ESALY NEWS
Tags ESALY Biotech Earnings
From Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
Tickers BIIB DGX ESALY LH
Tags ESALY News BIIB
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags ESALF General Briefs
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags PRTA Benzinga alzheimer's
From Benzinga
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
Tickers BIIB ESALY
Tags Movers Market News General
From Benzinga
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
Tickers BIIB ESALF ESALY LLY
Tags Benzinga Health Care Regulations
From Benzinga
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Tickers BIIB DGX ESALY LH
Tags RHHBY ESALY LH
From Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
Tickers BIIB ESALF ESALY LLY
Tags Benzinga Health Care Biotech
From Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Tickers AA AAPL AMZN BIIB
Tags AA ESALF SPY
From Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
Tickers BIIB ESALF ESALY
Tags General Briefs ESALF
From Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
Tickers ESALF ESALY MRK
Tags News Market News Large Cap
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
Tickers ESALF ESALY MRK
Tags Benzinga MRK Health Care
From Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Tickers BIIB ESALY RETA
Tags Market News Recent Press Releases RETA
From Motley Fool
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
Tickers BIIB ESALF ESALY
Tags Health Care Trading Ideas Benzinga
From Benzinga
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
Tickers BIIB ESALY
Tags Health Care Briefs General
From Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
Tickers AAPL ATVI BEP BIIB
Tags MSFT Benzinga Penny Stocks
From Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
Tickers BIIB ESALF ESALY
Tags Market News ESALF Briefs
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.